• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,728.37 -372.10
( -0.48%)
Global Indices
Nasdaq
52,219.26 322.15
(0.62%)
Dow Jones
7,463.83 88.81
(1.20%)
Hang Seng
69,178.80 -182.08
(-0.26%)
Nikkei 225
10,501.14 -6.88
(-0.07%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Biogen Pharmachem Industries Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
531752
INE703D01023
0.9409956
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
32
33.7
EPS(TTM)
Face Value()
Div & Yield %
0.01
1
0
 

rajratan global wire ltd
NOCIL consolidated net profit declines 18.23% in the March 2026 quarter
May 08,2026
Net profit of NOCIL declined 18.23% to Rs 17.00 crore in the quarter ended March 2026 as against Rs 20.79 crore during the previous quarter ended March 2025. Sales declined 2.75% to Rs 330.35 crore in the quarter ended March 2026 as against Rs 339.69 crore during the previous quarter ended March 2025.

For the full year,net profit declined 45.92% to Rs 55.63 crore in the year ended March 2026 as against Rs 102.86 crore during the previous year ended March 2025. Sales declined 6.44% to Rs 1302.97 crore in the year ended March 2026 as against Rs 1392.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales330.35339.69 -3 1302.971392.69 -6
OPM %6.3710.07 -7.739.87 -
PBDT34.6239.46 -12 136.26167.72 -19
PBT20.9525.97 -19 81.41114.14 -29
NP17.0020.79 -18 55.63102.86 -46